Disclosure of interest: Laurine Bedoucha : nothing to disclose Claire Gobron : nothing to disclose Fabrice Vallee : nothing to disclose Etienne Gayat : nothing to disclose Peggy Reiner : nothing to disclose Candice Sabben : nothing to disclose Michael Obadia : nothing to disclose Perrine Boursin : nothing to disclose Estelle Dubus : nothing to disclose Eric Jouvent : nothing to disclose Mikael Mazighi : nothing to disclose Lucas Di Meglio : nothing to disclose Poster Session I - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.01 - ACUTE MANAGEMENT - Neither thrombolysis nor thrombectomy P037 - ESOC25-504 CLINICAL AND ORGANISATIONAL PRACTICES IN THE ACUTE PHASE OF ISCHAEMIC STROKE IN QUEBEC BY SEX AND AGE: RESULTS OF A DESCRIPTIVE STUDY Amlie Blanger 1 , Julie Houle 1 , Line Beaudet 2 1 Universit du Qubec Trois-Rivires, Trois-Rivires, Canada, 2 Centre de recherche du Centre hospitalier de l'Universit de Montral (CRCHUM), Montral, Canada Background and Aims: The quality of interdisciplinary care during the acute phase of ischaemic stroke remains underexplored in Canada, particularly in Quebec
And thats the thing that happens when you get older
miR-16 and miR-125b are involved in barrier function dysregulation through the modulation of claudin-2 and cingulin expression in the jejunum in IBS with diarrhoea
TB-500 is designed to mimic these properties, and researchers often utilize it in studies focusing on wound healing and inflammation
KNOWN ADVERSE REACTIONS
Stacking / Combinations The blend is itself a stack the entire point is that it already combines the two peptides addressing the two main repair bottlenecks (supply via BPC-157, cell mobility via TB-500)
